Phentermine for pediatric obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 15 Dec 2025: Trial registered, NCT07282340
  2. 3 Jun 2026: Trial started, NCT07282340

The trials

NCT07282340: Phentermine's Impact on Treatment in Teens

State
Under way
Phase
Phase 2
People
240 planned
Started
3 Jun 2026
Primary completion
Jan 2028
Arms
Phentermine 16 mg Group
Results
None posted
  1. 15 Dec 2025: Trial registered
  2. 3 Jun 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Duromine, Ionamin, Qsiva, Qsymia component phentermine.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.